Abstract The present meta-analysis evaluated the efficacy and safety of empagliflozin + linagliptin combination compared with either monotherapy [n=6 randomized controlled trials; …

Jardiance (empagliflozin) and Tradjenta (linagliptin) are two prescription medications used to manage Type 2 diabetes, a condition characterized by high glucose or blood sugar levels. Type …

Mar 19, 2023 · In the United States empagliflozin/linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to

GLYXAMBI combines the power of 2 proven diabetes medications-empagliflozin and linagliptin, working together to lower A1C, along with diet and exercise. And in adults with type 2 diabetes …

SummaRy Linagliptin is a highly selective inhibitor of the enzyme DPP-4. It is one of several agents of this class now available for treatment of Type 2 diabetes. This review is based on a …

The approval of empagliflozin plus linagliptin was based on a double-blind, phase 3 clinical trial that compared the safety and efficacy of empagliflozin plus linagliptin with the individual drugs, …

Jan 11, 2022 · Background: Treatment of diabetes mellitus includes more than one drug of different groups, which may lead to a high pill burden and non-adherence to drugs. We have …

Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study.

Jan 1, 2018 · Areas covered: The aim of the review is to present the available data on pharmacokinetic properties/pharmacodynamics, metabolic and cardiovascular effects of …

In the initial therapy study, patients who had not received treatment with an oral antidiabetes therapy, GLP-1 analogue, or insulin for ≥ 12 weeks were randomized 1:1:1:1:1 to empagliflozin …